Healthcare / Medical DistributionXETRA
$13.46
-0.14 (-1.03%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $32.1M · quality 70.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$343M
P/E
15.5x
↓EV/EBITDA
7.4x
↓ROE
2.5%
↑Gross Margin
8.0%
↓Debt/Equity
0.47
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+11.5%
FCF CAGR
+11.4%
FCF margin
3.6%
FCF / Net income
5.37x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.88B · net income $12.5M · FCF $67.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.88B | $1.88B | $1.78B | $1.61B | $1.36B |
| Net Income | $12.5M | $12.5M | $18.8M | $18.3M | $7.4M |
| EBITDA | $64.0M | $64.0M | $52.8M | $51.3M | $34.7M |
| EPS | 0.51 | 0.51 | 0.79 | 0.77 | 0.37 |
| Gross Margin | 8.0% | 8.0% | 6.1% | 6.6% | 5.0% |
| Operating Margin | 1.6% | 1.6% | 1.7% | 1.7% | 1.0% |
| Net Margin | 0.7% | 0.7% | 1.1% | 1.1% | 0.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.47 | 0.47 | 0.04 | 0.04 | 0.13 |
| Current Ratio | 1.93 | 1.93 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $67.4M | $67.4M | $15.1M | $32.1M | $48.7M |
| Returns | |||||
| ROE | 2.5% | 2.5% | 4.0% | 4.1% | 1.9% |
| Valuation | |||||
| P/E | 15.47 | 15.47 | 19.27 | 24.03 | 94.05 |
| EV/EBITDA | 7.43 | 7.43 | 5.84 | 7.40 | 16.81 |
| P/B | 0.67 | 0.67 | 0.77 | 0.99 | 1.78 |
| Growth & Yield | |||||
| Revenue Growth | 5.5% | 5.5% | 10.8% | 18.7% | — |
| EPS Growth | -35.4% | -35.4% | 2.6% | 108.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
32.8%
EPS terminal req.
$1.19
Spread vs growth
-68.2%
5Y implied EPS CAGR
23.2%
EPS terminal req.
$1.45
Spread vs growth
-58.6%
10Y implied EPS CAGR
16.4%
EPS terminal req.
$2.33
Spread vs growth
-51.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+12.5%
Start / end P/E
15.1x → 26.4x
EPS bridge
0.79 → 0.51
Residual
-26.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.